atenolol has been researched along with Cancer of Esophagus in 2 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, P | 1 |
| Wu, WK | 2 |
| Wong, HP | 1 |
| Zhang, ST | 2 |
| Yu, L | 2 |
| Cho, CH | 2 |
| Liu, X | 1 |
| Li, ZJ | 1 |
| Sung, JJ | 1 |
2 other studies available for atenolol and Cancer of Esophagus
| Article | Year |
|---|---|
Chloroform extract of cigarette smoke induces proliferation of human esophageal squamous-cell carcinoma cells: modulation by beta-adrenoceptors.
Topics: Adrenergic beta-Antagonists; Atenolol; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferatio | 2009 |
Epidermal growth factor-induced esophageal cancer cell proliferation requires transactivation of beta-adrenoceptors.
Topics: Adrenergic beta-Antagonists; Atenolol; Cell Proliferation; Epidermal Growth Factor; Esophageal Neopl | 2008 |